<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01772966</url>
  </required_header>
  <id_info>
    <org_study_id>122008</org_study_id>
    <secondary_id>R01AT007311-01</secondary_id>
    <nct_id>NCT01772966</nct_id>
  </id_info>
  <brief_title>Chiropractic Manual Therapy and Neck Pain</brief_title>
  <official_title>Generalizing a Valid Control Manipulation to a Multiple Operator, Longitudinal Randomized Controlled Study for Chronic Neck Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Canadian Memorial Chiropractic College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Canadian Memorial Chiropractic College</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Eligible subjects with chronic neck pain will be randomly allocated to one of two&#xD;
      intervention groups: real vs control spinal manipulation. They will receive three&#xD;
      intervention sessions.&#xD;
&#xD;
      H1: Chronic neck pain patients treated longitudinally over a series of three encounters in&#xD;
      one week by random assignment to treatment group with either of the dual delivery procedures&#xD;
      (Intervention 1=typical-control or Intervention 2=control-control) will have a 50% error rate&#xD;
      of self-report of group allocation at exit interview.&#xD;
&#xD;
      H2: Patients treated by the typical-control dual procedure over a typical sequence of&#xD;
      encounters (3 times in one week) will show statistically significant improvement in clinical&#xD;
      outcomes; defined quantitatively by visual analogue pain scale (VAS), Neck Disability Index&#xD;
      (NDI), range of motion and pressure algometry; compared to those treated by the&#xD;
      control-control dual procedure.&#xD;
&#xD;
      H3: Patients stratified by 'a priori' patient expectation for treatment outcome will show no&#xD;
      significant difference in self-report of group allocation or clinical outcome measures.&#xD;
&#xD;
      A total of 372 subjects will be recruited.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Group registration</measure>
    <time_frame>At exit assessment following the third intervention session</time_frame>
    <description>Participants will be asked to identify which of the two interventions they feel they received.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain severity</measure>
    <time_frame>1. at baseline, and 2. At exit assessment following the third intervention session</time_frame>
    <description>Pain scores on the PROMIS pain severity instrument.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement</measure>
    <time_frame>At exit assessment following the third intervention session</time_frame>
    <description>Participants will be asked to rate their level of improvement on the The Global Rating of Change instrument.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disability</measure>
    <time_frame>1. at baseline, and 2. At exit assessment following the third intervention session</time_frame>
    <description>Participants will score the The Neck Disability Index (score out of 50).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tenderness</measure>
    <time_frame>1. at baseline, and 2. At exit assessment following the third intervention session</time_frame>
    <description>Pressure algometry over a single specified spinal site will be used to measure tenderness in kg/sq.sm.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of Participants with Adverse Events as a Measure of Safety</measure>
    <time_frame>Daily over 7-10 days.</time_frame>
    <description>All adverse events will be described and tallied. Adverse events will be categorized in two modes: 1] Serious vs. Not Serious, and, 2] Attributable to the trial vs. Not Attributable. Both the absolute number of adverse events as well as the percentage of subjects experiencing an adverse event will be reported.</description>
  </other_outcome>
  <other_outcome>
    <measure>Expectations related to improvement</measure>
    <time_frame>Baseline</time_frame>
    <description>Participants' expectations of the efficacy of the interventions will be obtained at baseline with the protocol of Fulda et al.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">319</enrollment>
  <condition>Chronic Mechanical Neck Pain</condition>
  <arm_group>
    <arm_group_label>Spinal manipulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive spinal manipulation delivered as segmental thrust to a specific site in the neck. They will receive three intervention sessions over 7-10 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control manipulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Participants will receive spinal manipulation delivered as non-segmental thrust to the neck. They will receive three intervention sessions over 7-10 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spinal manipulation</intervention_name>
    <arm_group_label>Control manipulation</arm_group_label>
    <arm_group_label>Spinal manipulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or Female&#xD;
&#xD;
          -  21 to 60 years of age&#xD;
&#xD;
          -  Chronic neck pain&#xD;
&#xD;
          -  Neck pain duration greater than 6 weeks&#xD;
&#xD;
          -  Numeric Rating Scale greater than 30, less than 65&#xD;
&#xD;
          -  Pain distribution between nuchal ridge and spine of the scapula&#xD;
&#xD;
          -  Pain aggravated by local provocation maneuvers at single motion segment&#xD;
&#xD;
          -  Antero-posterior glide&#xD;
&#xD;
          -  Paraspinal tenderness&#xD;
&#xD;
          -  Negative provocative maneuvers at adjacent segment&#xD;
&#xD;
          -  Able to tolerate neck movement to 50 percent normal in all directions&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Worker's compensation or other medico-legal claim&#xD;
&#xD;
          -  Cervical spine surgery or fracture or dislocation&#xD;
&#xD;
          -  Uncontrolled hypertension (Blood Pressure over 140 over 90)&#xD;
&#xD;
          -  Stroke or Transient Ischemic Attack&#xD;
&#xD;
          -  Upper respiratory infection within 4 weeks&#xD;
&#xD;
          -  Severe degenerative disease of the cervical spine&#xD;
&#xD;
          -  New or significantly altered pattern of headache complaint&#xD;
&#xD;
          -  Connective tissue disease&#xD;
&#xD;
          -  Primary fibromyalgia&#xD;
&#xD;
          -  Metabolic or metaplastic bone disease&#xD;
&#xD;
          -  Whiplash injury within 12 months&#xD;
&#xD;
          -  High cholesterol levels not well-managed medically&#xD;
&#xD;
          -  Cardiovascular surgery in the past 6 months or planned&#xD;
&#xD;
          -  Use of narcotic analgesic, prescription anti-inflammatory, or muscle relaxants,&#xD;
             anti-convulsants&#xD;
&#xD;
          -  Angina pectoris&#xD;
&#xD;
          -  Dizziness&#xD;
&#xD;
          -  Tinnitus&#xD;
&#xD;
          -  Blurred vision, vertigo, undiagnosed sensory and motor disturbances&#xD;
&#xD;
          -  Radicular symptoms and signs&#xD;
&#xD;
          -  Current use of anticoagulant therapy&#xD;
&#xD;
          -  Upper respiratory infection&#xD;
&#xD;
          -  Neck pain on provocation greater than 7 out of 10&#xD;
&#xD;
          -  Provocation of radicular pain or sensory disturbance&#xD;
&#xD;
          -  Hypermobility of multiple peripheral joints,&#xD;
&#xD;
          -  Physical or mental impairment precluding following instructions or participating -in&#xD;
             supine recumbent postures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Howard T Vernon, DC, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Canadian Memorial Chiropractic College</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Canadian Memorial Chiropractic College</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M2H 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <results_reference>
    <citation>Vernon H, MacAdam K, Marshall V, Pion M, Sadowska M. Validation of a sham manipulative procedure for the cervical spine for use in clinical trials. J Manipulative Physiol Ther. 2005 Nov-Dec;28(9):662-6.</citation>
    <PMID>16326235</PMID>
  </results_reference>
  <verification_date>October 2016</verification_date>
  <study_first_submitted>September 21, 2012</study_first_submitted>
  <study_first_submitted_qc>January 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2013</study_first_posted>
  <last_update_submitted>October 27, 2016</last_update_submitted>
  <last_update_submitted_qc>October 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>neck</keyword>
  <keyword>pain</keyword>
  <keyword>chronic</keyword>
  <keyword>manipulation</keyword>
  <keyword>control</keyword>
  <keyword>randomized trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neck Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

